Latest Breaking News On - ஹெலன் சென் - Page 1 : vimarsana.com

Share this article Share this article BC Cancer, CPHIN and Roche Canada will co-create an evidence-generating framework to leverage real-world data and facilitate cost-effective access to targeted treatments for cancer patients MISSISSAUGA, ON, May 28, 2021 /CNW/ - Hoffmann-La Roche Limited (Roche Canada) is pleased to announce a joint initiative with BC Cancer and the Canadian Personalized Healthcare Innovation Network (CPHIN) to co-create a real-world evidence (RWE) framework in British Columbia known as the PRecision Oncology Evidence Cancer Treatment (PREDiCT). The PREDiCT initiative will generate and assess RWE, which may be used to help shape new sustainable reimbursement pathways for personalized cancer treatments.

United kingdomRonnie millerHelen chenStephen yipClaire cockburnHealth services authorityCanadian personalized healthcare innovation networkRoche pharmaceuticals canadaBritish columbiaRoche pharmaceuticalsDean regierHoward limRoche canadaDiabetes careProvincial health services authorityHoffmann la roche